Related Experiment Video
Updated: Feb 21, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mastocytosis in Children
Nicholas Klaiber1, Santhosh Kumar1, Anne-Marie Irani2
1Department of Pediatrics, Division of Allergy and Immunology, Virginia Commonwealth University Health Systems, 1000 E Broad Street, Richmond, VA, 23219, USA.
Pediatric mastocytosis typically presents as skin lesions with a good prognosis and often resolves by adolescence. However, systemic mastocytosis is more severe and may continue into adulthood.
Area of Science:
- Pediatric Hematology
- Dermatology
- Immunology
Background:
- Mastocytosis is a rare disorder characterized by the abnormal proliferation of mast cells.
- Understanding its varied presentations and natural history in children is crucial for effective management.
Purpose of the Study:
- To review the current knowledge on pediatric mastocytosis, including its pathogenesis, clinical features, diagnosis, and treatment.
- To elucidate the natural history and prognosis of childhood mastocytosis.
Main Methods:
- Comprehensive literature review of pediatric mastocytosis.
- Analysis of pathogenesis, clinical manifestations, diagnostic approaches, and therapeutic strategies.
- Evaluation of disease progression and long-term outcomes.
Main Results:
- Pediatric mastocytosis commonly manifests as cutaneous lesions with a favorable prognosis and frequent spontaneous remission by adolescence.
- Systemic mastocytosis involving organ systems is a rarer, more severe form with a tendency to persist into adulthood.
- Emerging concepts like mast cell activation syndrome are also considered.
Conclusions:
- Early identification and appropriate management are key for pediatric mastocytosis.
- Distinguishing between cutaneous and systemic forms is vital for predicting disease course and prognosis.
- Further research into mast cell activation syndrome may offer new therapeutic avenues.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Differentiation of Common Myeloid Progenitor Cells
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Abnormal Proliferation
Pharmacokinetics in Pediatric Patients: Drug Distribution

